Cargando…

Comparison of Vancomycin Pharmacokinetics in Cystic Fibrosis Patients Pre and Post-lung Transplant

BACKGROUND: Vancomycin is commonly used to treat acute cystic fibrosis (CF) exacerbations associated with methicillin-resistant Staphylococcus aureus (MRSA). Multiple studies have demonstrated pharmacokinetic differences of antimicrobials in the CF population. Very little data exist regarding pharma...

Descripción completa

Detalles Bibliográficos
Autores principales:	White, Shannon, Sakon, Colleen, Fitzgerald, Linda, Kam, Charissa, McDade, Erin, Wong, Alanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297476/ https://www.ncbi.nlm.nih.gov/pubmed/32595284 http://dx.doi.org/10.1177/1179548420930925

Ejemplares similares

Vancomycin associated acute kidney injury in pediatric patients
por: Moffett, Brady S., et al.
Publicado: (2018)

Population Pharmacokinetics and Dosing Optimization of Vancomycin in Pediatric Liver Transplant Recipients
por: Shoji, Kensuke, et al.
Publicado: (2021)

1315. Ceftaroline Versus Vancomycin for the Treatment of Acute Pulmonary Exacerbations of Cystic Fibrosis in Adults
por: Esquivel, Marc, et al.
Publicado: (2021)

1323. Efficacy and Safety of Telavancin Compared to Vancomycin for Cystic Fibrosis Pulmonary Exacerbation in Adults
por: Shorman, Mahmoud, et al.
Publicado: (2021)

2663. Impact of Pre-Transplant Microbiology on Acute Outcomes in Cystic Fibrosis Patients Receiving Bilateral Lung Transplants
por: (Michael) Ji, Xincheng, et al.
Publicado: (2019)

Vancomycin Pharmacokinetic Parameters in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
por: Ghehi, Maryam Taghizadeh, et al.
Publicado: (2013)

Population Pharmacokinetics of Vancomycin in Kidney Transplant Recipients: Model Building and Parameter Optimization
por: Ma, Kui-fen, et al.
Publicado: (2020)

1119. Assessment of Vancomycin Pharmacokinetic Parameters in Pediatric Patients After Liver Transplantation
por: Morales, Ronaldo, et al.
Publicado: (2021)

Population Pharmacokinetics of Inhaled Tobramycin Powder in Cystic Fibrosis Patients
por: Ting, L, et al.
Publicado: (2014)

250 Dosing and therapeutic drug monitoring of intravenous vancomycin in cystic fibrosis: A practice survey
por: Dagenais, R., et al.
Publicado: (2022)

Population Pharmacokinetics of Vancomycin in Thai Patients
por: Purwonugroho, Tunggul Adi, et al.
Publicado: (2012)

Population Pharmacokinetics of Vancomycin in Pregnant Women
por: Goyal, Rahul K., et al.
Publicado: (2022)

Pharmacokinetics of Vancomycin in Pediatric Patients Receiving Intermittent Hemodialysis or Hemodiafiltration
por: Chung, Erin, et al.
Publicado: (2021)

Evaluation of the Risk for Acute Kidney Injury in Adult Cystic Fibrosis Patients Receiving Concomitant Vancomycin and Tobramycin
por: Muirhead, Corinne, et al.
Publicado: (2017)

Pseudomonas aeruginosa Alters Staphylococcus aureus Sensitivity to Vancomycin in a Biofilm Model of Cystic Fibrosis Infection
por: Orazi, Giulia, et al.
Publicado: (2017)

426 Association between pre-transplant Staphylococcus aureus colonisation and post-transplant S. aureus infection among cystic fibrosis lung transplant recipients
por: St-Pierre, Jessica, et al.
Publicado: (2014)

Clinical pharmacokinetics of vancomycin in the neonate: a review
por: Pacifici, Gian Maria, et al.
Publicado: (2012)

Transportan 10 improves the pharmacokinetics and pharmacodynamics of vancomycin
por: Ruczyński, Jarosław, et al.
Publicado: (2019)

Population pharmacokinetics and dose optimization of vancomycin in neonates
por: Lee, Soon Min, et al.
Publicado: (2021)

Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis
por: Hirche, T. O., et al.
Publicado: (2014)

Telemonitoring: An opportunity in cystic fibrosis lung transplant recipients
por: Corinna Morlacchi, Letizia, et al.
Publicado: (2023)

An Open-Label Investigation of the Pharmacokinetics and Tolerability of Oral Cysteamine in Adults with Cystic Fibrosis
por: Devereux, Graham, et al.
Publicado: (2016)

Pharmacokinetics of Meropenem in People with Cystic Fibrosis—A Proof of Concept Clinical Trial
por: Kamp, Jan C., et al.
Publicado: (2021)

Clinical pharmacokinetics and dose recommendations for posaconazole gastroresistant tablets in children with cystic fibrosis
por: Bentley, Siân, et al.
Publicado: (2021)

Gene Polymorphism of Biotransformation Enzymes and Ciprofloxacin Pharmacokinetics in Pediatric Patients with Cystic Fibrosis
por: Zyryanov, Sergey K., et al.
Publicado: (2022)

Pharmacokinetics of Intraperitoneal Vancomycin and Amikacin in Automated Peritoneal Dialysis Patients With Peritonitis
por: Falbo dos Reis, Pâmela, et al.
Publicado: (2021)

Low Beta-Adrenergic Sweat Responses in Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome Children
por: Salinas, Danieli Barino, et al.
Publicado: (2017)

Genetic Influences on Cystic Fibrosis Lung Disease Severity
por: Weiler, Colleen A., et al.
Publicado: (2013)

Predictive performance of Vancomycin population pharmacokinetic models in Iranian patients underwent hematopoietic stem cell transplantation
por: Taghizadeh-Ghehi, Maryam, et al.
Publicado: (2015)

2226. Trough- Versus AUC-Based Vancomycin Monitoring for Treatment of Acute Pulmonary Exacerbations of Adult Cystic Fibrosis Patients
por: Smith, Darrell, et al.
Publicado: (2023)

Age at Lung Transplant Impacts Post-Transplant Survival in Cystic Fibrosis; Why?
por: Clausen, Emily S., et al.
Publicado: (2021)

Cystic fibrosis-related diabetes: The patient perspective()
por: Mason, Kelly A., et al.
Publicado: (2021)

α-Tocopherol Pharmacokinetics in Adults with Cystic Fibrosis: Benefits of Supplemental Vitamin C Administration
por: Traber, Maret G., et al.
Publicado: (2022)

Myocardial infarction in an adult with cystic fibrosis and heart and lung transplant
por: Eaden, James, et al.
Publicado: (2013)

Erratum to “Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis”
por: Hirche, T. O., et al.
Publicado: (2015)

Bilateral lobar lung transplantation for cystic fibrosis – first in Poland
por: Nieborak-Raczkowska, Marta, et al.
Publicado: (2019)

COVID-19 in lung-transplanted and cystic fibrosis patients: Be careful
por: Farfour, Eric, et al.
Publicado: (2020)

Major Decrease in Lung Transplantation for Patients with Cystic Fibrosis in France
por: Martin, Clémence, et al.
Publicado: (2021)

Lung Transplantation in a New Era in the Field of Cystic Fibrosis
por: Huang, Wei, et al.
Publicado: (2023)

Legionella and the Prevention of Legionellosis
por: McDade, Joseph E.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_e66rfu14dvtns5pvdrnj0c1vb5